Ethnicity and weight status affect the accuracy of proxy indices of insulin sensitivity

Obesity

Volumn 16, Issue 12, 2008, Pages 2739-2744

  Alvarez, Jessica A ^a   Bush, Nikki C ^a   Hunter, Gary R ^a   Brock, David W ^b   Gower, Barbara A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; CAUCASIAN; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; METABOLISM; OBESITY; REPRODUCIBILITY; STATISTICS; VALIDATION STUDY; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADULT; AFRICAN AMERICANS; BLOOD GLUCOSE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; OVERWEIGHT; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC; WEIGHT GAIN;

EID: 58149280425     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.437     Document Type: Article

References (34)

1. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002;40:937-943.
2. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-2776.
3. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-E223.
4. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467.
5. Tripathy D, Almgren P, Tuomi T, Groop L. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 2004;27:2204-2210.
6. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419.
7. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
8. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-2698.
9. Haffner SM, D'Agostino R, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-748.
10. Garcia-Estevez DA, raujo-Vilar D, Fiestras-Janeiro G, Saavedra-Gonzalez A, Cabezas-Cerrato J. Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices. Horm Metab Res 2003;35:13-17.
11. Kim SH, Abbasi F, Reaven GM. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004;27:1998-2002.
12. Mather KJ, Hunt AE, Steinberg HO et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001;86:5457-5464.
13. Vaccaro O, Masulli M, Cuomo V et al. Comparative evaluation of simple indices of insulin resistance. Metabolism 2004;53:1522-1526.
14. Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 1996;19:1404-1411.
15. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 1997;46:456-462.
16. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88-98.
17. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-1585.
18. Bonora E, Del PS, Bonadonna RC et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992;41: 1151-1159.
19. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-122.
20. Kekes-Szabo T, Hunter GR, Nyikos I, Nicholson C, Snyder S, Berland L. Development and validation of computed tomography derived anthropometric regression equations for estimating abdominal adipose tissue distribution. Obes Res 1994;2:450-457.
21. Smith SR, Lovejoy JC, Greenway F et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001;50:425-435.
22. Siegel S, Castellan NJ Jr. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill: New York, 1988.
23. Bergman RN, Hope ID, Yang YJ et al. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 1989;5:411-429.
24. Paquot N, Scheen AJ, Dirlewanger M, Lefebvre PJ, Tappy L. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obes Res 2002;10:129-134.
25. Gastaldelli A, Cusi K, Pettiti M et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007;133:496-506.
26. Barzilai N, She L, Liu L et al. Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action. Am J Physiol 1999;277 (2 Pt 1):E291-E298.
27. Bergman RN, Van Citters GW, Mittelman SD et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001;49: 119-126.
28. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003;111:225-230.
29. Stefan N, Stumvoll M, Vozarova B et al. Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 2003;26: 3315-3319.
30. Bonora E. Relationship between regional fat distribution and insulin resistance. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S32-S35.
31. Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002;87:5044-5051.
32. Hays NP, Starling RD, Sullivan DH et al. Comparison of insulin sensitivity assessment indices with euglycemic-hyperinsulinemic clamp data after a dietary and exercise intervention in older adults. Metabolism 2006;55:525-532.
33. Duncan GE, Hutson AD, Stacpoole PW. QUICKI does not accurately reflect changes in insulin sensitivity with exercise training. J Clin Endocrinol Metab 2001;86:4115-4119.
34. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.